Trademarks

PEBBLE LABS

Serial number
88225549
Registration number
5819332
Filed
2018-12-11
Registered
2019-07-30
Status
Registration cancelled 2026-02-13 (USPTO status code 710, 2026-02-13; as of the dataset)
Classes
042
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRTDXFAP, file of 2026-03-11

Goods and services

Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Design and development of biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals for use in pharmaceuticals, biotechnology, and medical and diagnostic applications; Research and development of biopharmaceutical compounds; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce eukaryotic-like mRNA; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce commercial compounds; Research and development of genetically engineered organisms, namely, genetically engineered algae that produce that produce waxes; Research and development of pharmaceuticals, therapeutics, and biologics; Research and development of new biological products for therapeutic use

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Pebble Labs Inc.Original applicant, Owner at publication, Original registrantCorporationLos Alamos, NM, CAPebble Labs Inc. Form D issuer EXACT high confidence: identical full name and stateTRTDXFAP, file of 2026-03-11
PEBBLE LABS INC.New owner after registrationCorporationSANTA FE, NMPebble Labs Inc. Form D issuer EXACT high confidence: identical full name and stateTRTDXFAP, file of 2026-03-11
PEBBLE LABS, INC.New owner after registrationCorporationLOS ALAMOS, NMPebble Labs Inc. Form D issuer EXACT high confidence: identical full name and stateTRTDXFAP, file of 2026-03-11

Assignment history

RecordedWhatFromToReel/frameSource
2020-12-13Assignment
Assigns the entire interest
PEBBLE LABS INC.PEBBLE LABS, INC. LOS ALAMOS, NM7131/427TRASECO, file of 2026-09-29
2019-09-23Assignment
Assigns the entire interest
PEBBLE LABS INC.PEBBLE LABS INC. SANTA FE, NM6759/849TRASECO, file of 2026-09-29

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.